erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

�we are glad that, at last, the commission is taking serious steps to fight air pollution before the court of justice,� clientearth lawyer ugo taddei said in a press release...